VanEck Vectors Pharmaceutical ETF (PPH)

NASDAQ: PPH · IEX Real-Time Price · USD
68.36
+1.63 (2.44%)
Sep 28, 2022 4:00 PM EDT - Market closed
2.44%
Assets $496.47M
NAV $66.73
Expense Ratio 0.35%
PE Ratio 19.84
Shares Out 7.44M
Dividend (ttm) $1.31
Dividend Yield 1.91%
Ex-Dividend Date Jul 1, 2022
1-Year Return -6.11%
Volume 354,826
Open 67.60
Previous Close 66.73
Day's Range 67.44 - 68.60
52-Week Low 66.59
52-Week High 84.27
Beta 0.77
Holdings 26
Inception Date Feb 1, 2000

About PPH

The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The index includes common stocks and depositary receipts of U.S. exchange-listed companies in the pharmaceutical industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.

Asset Class Equity
Sector Healthcare
Region Global
Issuer Van Eck Associates
Stock Exchange NASDAQ
Ticker Symbol PPH
Index Tracked MVIS US Listed Pharmaceutical 25 Index

Top 10 Holdings

56.13% of assets
Name Symbol Weight
Johnson & Johnson JNJ 9.39%
AbbVie ABBV 5.84%
Eli Lilly and Company LLY 5.61%
Bristol-Myers Squibb Company BMY 5.37%
Pfizer PFE 5.37%
Merck & Co. MRK 5.22%
Novartis AG ADR NVSN.MX 4.91%
Novo Nordisk NVO 4.88%
AstraZeneca AZN 4.77%
Haleon HLN 4.77%
View More Holdings

Dividends

Ex-Dividend Amount Pay Date
Jul 1, 2022 $0.2496 Jul 8, 2022
Apr 1, 2022 $0.4429 Apr 7, 2022
Dec 29, 2021 $0.2691 Dec 31, 2021
Oct 1, 2021 $0.3453 Oct 7, 2021
Jul 1, 2021 $0.2859 Jul 8, 2021
Apr 1, 2021 $0.3497 Apr 8, 2021
Full Dividend History

News

Should You Invest in the VanEck Pharmaceutical ETF (PPH)?

Sector ETF report for PPH

1 month ago - Zacks Investment Research

Pharma Stocks, ETFs Can Deal With Drug Pricing Legislation

This is a mid-term election year, meaning that some familiar issues investors should be aware of are popping up yet again. That includes reducing pharmaceutical prices.

2 months ago - ETF Trends

Wall Street on Track for Worst 1H: 4 Top-Ranked ETFs Win

While there have been losers in many corners of the space, we highlight five ETFs from different industries that have gained in the first half of the year.

Other symbols: FDLKBWPPXE
2 months ago - Zacks Investment Research

Pharma ETFs in Focus Post Q1 Earnings

Many industry bigwigs reported solid results with some beating on earnings or revenues or both.

Other symbols: FTXHIHEPJPXPH
4 months ago - Zacks Investment Research

Solid Q4 Earnings Fail to Impress Pharma ETFs

Solid earnings failed to impress pharma ETFs over the past month due to a broad sell-off in the market.

Other symbols: FTXHIHEPJPXPH
7 months ago - Zacks Investment Research

Pharmaceuticals Stocks, ETFs Could Have Power Beyond 2022

Pharmaceuticals stocks and the related exchange traded funds are benefiting from the now-steady revenue stream provided by coronavirus vaccines, but with that priced into many pharmaceuticals equities, ...

7 months ago - ETF Trends

Pharma Could Be Place to Be for Healthcare Winners, Value

Broadly speaking, the healthcare sector delivered some decent though not spectacular performances last year, with diversified exchange traded funds addressing the sector hindered by rough showings by bi...

8 months ago - ETF Trends

Pharma Could Be Fabulous in 2022

Pharmaceuticals stocks and the related exchange traded funds are turning solid performances in 2021. Investors looking for quality and growth traits might want to continue leaning on this corner of the ...

9 months ago - ETF Trends

Write a Prescription for Pharma Dividends With PPH

Domestic dividend growth is on a torrid pace this year, and market observers expect that the trend will continue in 2022. Investors searching for sector and industry exchange traded funds with which to ...

9 months ago - ETF Trends

Omicron Variant Could Be Potent for Pharma Stocks, ETFs

According to reports out Wednesday, the first U.S case of the Omicron variant of the coronavirus was discovered in California. More research is needed on the Omicron strain, but there's already ample ch...

9 months ago - ETF Trends

There's Power Lurking in This Pharma ETF

Blue-chip pharmaceuticals stocks are turning solid showings this year, but the group is lagging the broader market, indicating that some of the coronavirus vaccine blush is wearing off the group. Howeve...

10 months ago - ETF Trends

PPH Pertinent as Some Cheap Pharma Stocks Offer Big Dividend Growth

Healthcare stocks are solid but not spectacular performers. For example, the S&P 500 Health Care Index is higher by more than 17%, though that lags the broader market.

10 months ago - ETF Trends

Wave of Solid Q3 Earnings Push Pharma ETFs Higher

The slew of Q3 results has led to smooth trading in pharma ETFs over the past month.

Other symbols: FTXHIHEPJPXPH
10 months ago - Zacks Investment Research

Strong Vaccine Demand Lifting Pharma Sales

There are multiple coronavirus vaccines on the market, and with the likelihood of booster shots increasing by the day, the revenue outlook for healthcare exchange traded funds, including the VanEck Vect...

1 year ago - ETF Trends

Should You Invest in the VanEck Vectors Pharmaceutical ETF (PPH)?

Sector ETF report for PPH

1 year ago - Zacks Investment Research

Pharma ETFs Gain on Q2 Earnings

Many industry bigwigs reported solid results with some beating on earnings or revenues or both.

Other symbols: FTXHIHEPJPXPH
1 year ago - Zacks Investment Research

Alzheimer's Drug Cost Pushes Pharmaceutical Prices Back Into the Spotlight

Biogen's (NASDAQ: BIIB) Aduhelm sparked a rally in the biotech giant's share price and hope that progress is being made in treating Alzheimer's. However, the news isn't free of controversy, and carries ...

1 year ago - ETF Trends

Pharma & Healthcare ETFs at a One-Year High: Here's Why

Upbeat earnings, COVID-19-related sales, compelling valuation and lucrative dividend prospects are boosting pharma and healthcare ETFs.

Other symbols: FXHIEIHIHEPJP
1 year ago - Zacks Investment Research

Artificial Intelligence Set to Transform the Pharmaceutical Industry

The pharmaceuticals industry got a boost last year when a Covid-19 vaccine was introduced, but artificial intelligence (AI) could keep the sector and ETFs like the VanEck Vectors Pharmaceutical ETF (PPH...

1 year ago - ETF Trends

7 Pharmaceutical Stocks That Could Get a Covid Hangover

Pharmaceutical stocks gained a lot from the pandemic and the race to vaccines, but most of that upside is off the table now. The post 7 Pharmaceutical Stocks That Could Get a Covid Hangover appeared fir...

1 year ago - InvestorPlace

Pharma Goes Beyond the Vaccine. ‘PPH' on the Verge of More Advances

Coming off a vaccine rally that started in the middle of 2020, the pharmaceutical industry will continue to evolve as technological advances make their way into the sector, which should help ETFs like t...

1 year ago - ETF Trends

Pharma ETFs in Focus Post Q4 Earnings

Healthcare Q4 results seem robust given that it is the fourth-best sector from a revenue growth look and the sixth-strongest in terms of earnings growth.

Other symbols: FTXHIHEPJPXPH
1 year ago - Zacks Investment Research

ETFs to Tap AstraZeneca Mega-Deal to Buy Alexion

AstraZeneca has agreed to buy rare-disease specialist Alexion Pharmaceuticals for $39 billion. The deal would represent the biggest transaction in pharmaceuticals since 2019.

Other symbols: BBHFBTPBEPJP
1 year ago - Zacks Investment Research

Beyond the Vaccine: The Long Runway for Health and Pharmaceutical ETFs

With 2020 election season in the rearview mirror, it could be a great time to revisit health and pharmaceutical ETFs, including the VanEck Vectors Pharmaceutical ETF (NASDAQ: PPH). PPH tracks the MVIS U...

1 year ago - ETF Trends

Write A Prescription For This Pharma ETF

After scuffling amid political uncertainty leading up to Election Day, pharmaceutical stocks and exchange-traded funds are finally perking amid a spate of encouraging news regarding coronavirus vaccine ...

1 year ago - Benzinga